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UWill Discover Abstract 
 
Hepatocellular carcinoma (HCC) is among the most aggressive and prevalent forms of 
primary liver cancer. With an increasing incidence in Canada and only a five-year survival rate 
of 19%, a more comprehensive understanding of this debilitating disease is imperative in order to 
consider future treatment options. A variety of lifestyle factors may underlie HCC, including 
chronic alcoholism, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis 
(NASH). These factors are known to elicit liver injury, inflammatory immune responses, and 
oxidative damage thereby imparting a regenerative response in this visceral organ. This 
regeneration is manifested as either fibrosis, in order to maintain structural integrity of the organ, 
or through hepatocyte proliferation, in order to restore functional mass. Progression through the 
cell cycle by the normally quiescent hepatocytes is thought to contribute to the proliferative 
response. Spy1 is a novel, cyclin-like protein, which binds and activates CDKs at the G1-S and 
G2-M checkpoints, leading to cell cycle progression independent of cyclin-based regulation. A 
serendipitous discovery in the transgenic MMTV-Spy1 murine model demonstrates that Spy1 
significantly increases the incidence of fatty liver disease and HCC. Combined with a 
methionine-choline deficient (MCD) diet in order to elicit liver injury, the MMTV-Spy1 murine 
livers response to these factors through inflammatory, proliferative and fibrotic responses is 
analyzed. Preliminary evidence demonstrates Spy1’s role in favouring hepatic regeneration 
through a proliferative response rather than a fibrotic one, demonstrating a potential mechanism 
in the development of HCC. Through primary cultures of THLE-2 and Hep G2 cell lines, similar 
assays are conducted in order to determine Spy1’s role in causing liver cancer. These results will 
shed light on Spy1’s role in HCC, potentially allowing for determination of a diagnostic markers 
and pathways of therapeutic importance. 
 
 
